Topics

Bayer Joins Sensyne Health Consortium Working on National Linked Patient Data Capability for Accelerating the Discovery of New Medicines

08:00 EDT 2 May 2019 | EHEALTHNEWS.EU

BayerSensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together on the development of a national linked patient data capability. Bayer joins Microsoft, EY, JP Morgan, and Peel Hunt in this consortium.

Original Article: Bayer Joins Sensyne Health Consortium Working on National Linked Patient Data Capability for Accelerating the Discovery of New Medicines

NEXT ARTICLE

More From BioPortfolio on "Bayer Joins Sensyne Health Consortium Working on National Linked Patient Data Capability for Accelerating the Discovery of New Medicines"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...